Rob Camerer Email & Phone Number

Springfield, Mo, Us

USA's NUMBER ONE PHARMACEUTICAL LICENSING AND BUSINESS DEVELOPMENT COMPANY SINCE 2006, Responsible for out-licensing and some in-licensing of generic pharmaceutical developments, OSD, Opthalmic, Injectables (various including carbopenems) from a well known european generic drug development company into North America directly to more than 30 generic pharmaceutical companies. Responsible for: Letter of Intent (Term Sheets), Agreement drafting and review, negotiations, product pipeline development and review, customer satisfaction, networking for company to build business, project management of signed deals, collections, trade shows, travel, entertainment, monthly meeting attendance in Europe, accounting of US business, budgeting and moreUS Deals - over 150 generic pharma products licensed in US since 2006 in US and Canada. Canadian Deals - approximately 20 products licensed in Canada since 2006Specialty - Paragraph IV, First to File, 505(b)(2)’s, orphan drugs, Rems, taking API companies to finished dose, turn key developments Other Experience: Branded PharmaceuticalsPeripheral experience: API sourcing, API Selection, API procurement, chemicals, Quality Control, Quality Assurance, Manufacturing of finished product, SAP, Oracle, sales management, operations management, other...

Springfield, Mo, Us

Market place for buying and selling of ANDA's and NDA's Please bring your Abbreviated New Drug Applications (ANDA's), New Drug Applications (NDA's), Marketing Authorizations (MA's) that you have for sale to ANDAExchange (see ANDAExchange.com) and we will support you fully in promotion, marketing, negotiating of high level terms, due-diligence with the buyer, and final negotiations of the definitive agreements with the buyer for the assets. We are not a party to the agreements but only facilitate the buying and selling. www.andaexchange.com

Dynamic and Experienced Leader of the Aggrega Pharma, LLC (formerly GPP Consortium, LLC) comprised of 6 key members (shareholders) including GPP. Mission is to take high performing low to medium risk projects from start to finish relative to generic development of products, filing with regulatory agency, achieving approval, and then launching through our VSMC (Virtual Sales and Marketing Corporation).Allowing those R&D members to have an very profitable low risk option of developing high risk high barrier to entry products by sharing the costs, technology, manufacturing, regulatory, and any other hurdles with the 6 Members who all have excellent but different in many cases, core competencies. Proven strategy allowing Members to avoid high costs of establishing or acquiring own VSMC at cost of multi-millions annually taking all risk where Consortium model spreads this risk and the rewards over several members. Multi million and in case multi hundred million turnover with some of our Members allowing resources to move forward the 10 year business planAlso looking for strategic investors who will allow the well experienced management to continue to do what management does best at the Consortium which is to operate the business in a very high performing manner. Business plan calls for $40 million in turnover by 2020.Assets are the 6 members company personnel and their vast experience in all forms of taking a development from conception to completion, filing and launching products in to the market.

Amstelveen, North Holland, Nl

Founder and VP of the Pharmathen US Division

Chesterfield, Mo, Us

Responsible for out-licensing of Branded and Generic Pharmaceuticals in over 50 countries. Responsible for monitoring and establishing distributorships of value added API's in over 30 countries. Setting up distribution of API and managing performance

Pharmaceutical Desiccant Manufacturing, Sales, Marketing, R&D, Quality, Human Resources, Operations, Finance, Business Development

Reedville, Virginia, Us

Managed 5 manufacturing sites encompassing 4 States and over 500 personnel

Zug, Ch

Full P&L responsibilities over operations, sales, marketing, finance, 8 direct reports and 211 personnel

St. Louis, Missouri, Us

Re-engineered and downsized group from 220 personnel to 47 in 2 years while increasing productivity and revenues. Monsanto business unit in St Louis Missouri (47 employees in my group with 7 direct reports). Managed the Phosphoric Acid division supplying product to Coca Cola and many other key clients

Design, procure, construct, test, commercial launch, and operation chemical systems my team and I had designed

Bachelor Of Science (B.Sc.), Chemical Engineering

Master Of Business Administration (Mba), International/Global Studies

Bachelor Of Science (Bs), Chemistry